Acumen Pharmaceuticals Inc.

01/09/2025 | Press release | Distributed by Public on 01/09/2025 07:00

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.